title: IGHV and Interphase Cytogenetics in a Patient With Chronic Lymphocytic Leukemia.
authors.affiliation: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus.
authors.forename: John C
authors.initials: JC
authors.lastname: Byrd
authors.affiliation: Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus.
authors.forename: Meixiao
authors.initials: M
authors.lastname: Long
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics*; D020732:Cytogenetic Analysis; D004252:DNA Mutational Analysis; D005260:Female; D050438:Genes, Immunoglobulin Heavy Chain; D020022:Genetic Predisposition to Disease; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D008875:Middle Aged; D009154:Mutation; D010641:Phenotype; D010880:Piperidines; D011237:Predictive Value of Tests; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine